Search - tctmd.com

Displaying 341 - 360 of 585

Sort: Relevancy | Date

News Daily News

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

L.A. McKeown

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

News Daily News

研究结果支持ACS患者的DAPT治疗持续3个月以上

L.A. McKeown

November 01, 2013

Presentation TCT 2013

Cases V and VI: Acute Coronary Syndromes

Presenter: Allen Jeremias

October 31, 2013

Presentation TCT 2013

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Presenter: Pieter Stella

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

Presentation TCT 2013

IVUS in Patients with Acute Coronary Syndromes

Presenter: Hector Garcia-Garcia

October 30, 2013

Presentation TCT 2013

FFR in Patients with Acute Coronary Syndromes

Presenter: Habib Samady

October 30, 2013

Presentation TCT 2013

TCT-18. Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study

Presenter: Ankit Garg

October 29, 2013

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Presentation TCT 2013

TCT-46. Effects of Radial versus Femoral Accesses for Percutaneous Coronary Interventions in Octogerians with Acute Coronary Syndromes

Presenter: Elmir Omerovic

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

Presentation TCT 2013

Acute Coronary Syndromes: STEMI

Presenter: Michael Kim

October 27, 2013

Presentation TCT 2013

Acute Coronary Syndromes: NSTEMI

Presenter: Ziad Ali

October 27, 2013

News Daily News

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Caitlin E. Cox

October 25, 2013

News Daily News

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Caitlin E. Cox

October 25, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Advertisement

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

研究结果支持ACS患者的DAPT治疗持续3个月以上

Cases V and VI: Acute Coronary Syndromes

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

IVUS in Patients with Acute Coronary Syndromes

FFR in Patients with Acute Coronary Syndromes

TCT-18. Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

TCT-46. Effects of Radial versus Femoral Accesses for Percutaneous Coronary Interventions in Octogerians with Acute Coronary Syndromes

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Acute Coronary Syndromes: STEMI

Acute Coronary Syndromes: NSTEMI

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content